Joachim N Nilsson

9PUBLICATIONS
22CO-AUTHORS
Radiation therapyPredictive and prognostic markersSynchrotronsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 18, 2026
Fraction-dependent dose dynamics and clinical safety in high-risk neuroblastoma treated with [177Lu]Lu-DOTATATE: results from the LuDO-N trial.

|Feb 21, 2025
Comprehensive Gene Expression Analysis in Papillary Thyroid Carcinoma Reveals a Transcriptional Profile Associated with Reduced Radioiodine Avidity.

Vincenzo Condello, Carlotta Marchettini, Catharina Ihre-Lundgren

|Jan 26, 2025
Count-rate management in 131I SPECT/CT calibration.

Staffan Jacobsson Svärd, Cecilia Hindorf, Joachim N Nilsson

|Feb 06, 2024
Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy.

Märta Persson, Cecilia Hindorf, Oscar Ardenfors

|Jun 23, 2023
Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up.

Joachim N Nilsson, Jonathan Siikanen, Vincenzo Condello

|Jun 07, 2023
Primary tumour iodine avidity in relation to uptake in persistent metastatic disease in papillary and poorly differentiated thyroid cancer.

Joachim N Nilsson, Per Grybäck, C Christofer Juhlin

Pageof 2

Frequent Collaborators

4 joint publications

C Christofer Juhlin

3 joint publications

Daniel Thor

3 joint publications

Oscar Ardenfors

2 joint publications

Christel Hedman